Data & Analytics

Major brands and tech firm Rokt join the AHA's new initiative, using AI and the power of retail to fight the leading cause of death among women.

Terra Firma Energy's new sites delivered power for 6,700 homes, proving the vital role of flexible generation in balancing the grid and keeping the lights on.

Marex's acquisition of Webb Traders signals a major push into automated equity derivatives, aiming to internalize hedging and challenge market norms.

With battery fires on the rise, Wanxiang A123 has unveiled a new semi-solid-state and immersion-cooled system designed to eliminate thermal runaway.

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

BlackRock's integration of Preqin data into its eFront platform creates a single, AI-driven solution, bringing public market transparency to private assets.

A new partnership will integrate data from millions in India and the UAE, aiming to fix research bias and build more equitable AI-driven medicine.

A new partnership between Verity and Bushel connects on-farm data to clean fuel markets, promising a new era of revenue for sustainable farming practices.

A new data intelligence platform with 90M data points aims to transform how hospitals manage stroke programs, promising new clarity and a competitive edge.

GMMB promotes digital strategist Erica Monteith and ad maker Jodi Quintero, signaling a deep investment in data-driven innovation and powerful advocacy.

Venbrook Group names Awais Farooq its new Chief Claims Officer, signaling a major strategic push to modernize its global claims with data and technology.

A world-first trial for personalized mRNA vaccines offers new hope for children with aggressive brain tumors, a mission born from a father's own fight.

MetaVia's drug vanoglipel gets a major boost from AI modeling, validating its potential to treat complex metabolic diseases like MASH and Type 2 Diabetes.

A new study reveals financial firms see big returns from AI but struggle with deployment due to poor data quality and IT complexity, forcing a major rethink.

Affinia Therapeutics gets the green light for a human trial of AFTX-201, a one-time therapy for a devastating genetic heart disease, BAG3 DCM.

After uniting nine acquired firms under one brand, NowVertical is shifting its focus to organic growth, leveraging integrated operations to exceed targets.

A powerful new genomic tool is turning genetic doubt into diagnostic certainty, helping thousands of patients understand their true hereditary cancer risk.

With a 90% clinical trial failure rate, BullFrog AI is launching a new tool to help drugmakers make smarter, risk-balanced R&D decisions.

Amidst economic headwinds, JD Power projects 16.3M vehicle sales for 2026 and launches its new 'Power Platform' to help the industry navigate disruption.

EXL has been named a leader in healthcare for the fourth year. We explore how its data and AI strategy is driving efficiency and better patient outcomes.